Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults

NCT00192465 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: MEDI-524 (Numax-TM)
BIOLOGICAL: MEDI-524 (Numax-TM)
BIOLOGICAL: MEDI-524 (Numax-TM)
BIOLOGICAL: MEDI-524 (Numax-TM)
BIOLOGICAL: MEDI-524 (Numax-TM)

Sponsor

MedImmune LLC